Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: summary

J Bone Miner Metab. 2014 Jan;32(1):10-6. doi: 10.1007/s00774-013-0495-0. Epub 2013 Sep 26.

Abstract

Osteoporosis is recognized as a major public health problem worldwide and in Taiwan. However, many patients with osteoporotic fractures do not receive appropriate assessments or treatments. This guideline, proposed by the Taiwanese Osteoporosis Association, is to serve as a quick reference for healthcare providers to improve the assessment of osteoporosis and development of optimal strategies for osteoporotic management in Taiwan. To review and update osteoporosis management, the guideline is constituted with Taiwan-specific osteoporosis epidemiological data, medication protocols, and the 10-year FRAX(®). The guideline is based on evidence-based medicine and public health considerations. Recommendations are not limited to the reimbursement regulations permitted by the National Health Insurance of Taiwan.

Publication types

  • Review

MeSH terms

  • Bone Density / drug effects
  • Bone Density Conservation Agents / pharmacology
  • Bone Density Conservation Agents / therapeutic use
  • Bone Remodeling / drug effects
  • Humans
  • Osteoporosis / diagnostic imaging
  • Osteoporosis / physiopathology
  • Osteoporosis / prevention & control*
  • Osteoporosis / therapy*
  • Practice Guidelines as Topic*
  • Public Health
  • Radiography
  • Taiwan

Substances

  • Bone Density Conservation Agents